Jason Gilbert Giambi's Net Worth as of 2024
$35 Million
Jason Gilbert Giambi was born on 8 January 1971, in West Covina, California USA, to Jeanne and John Giambi. He is a former professional baseball player, best known for playing for the Oakland Athletics and New York Yankees in Major League Baseball(MLB).
So just how rich is Jason Giambi at present? According to sources in late 2016, Giambi’s net worth reaches $35 million; his assets include a luxury villa – Casa Cielo in Cabo San Lucas, Mexico, of which he is a co-owner. Giambi has accumulated his wealth largely through his baseball career which stretched over 20 years.
Jason Giambi Net Worth $35 Million
Giambi grew up in West Covina, along with his two siblings, his brother being Jeremy Giambi, also a baseball player. He attended Sacred Heart Middle School in Pittsburgh, and later enrolled in South Hills High School in his West Covina, where he excelled in baseball, leading his team to the state finals in his senior year and being named MVP. He was also an avid basketball and football player during his high school days.
Upon matriculating, Giambi was selected in the 43rd round by the Milwaukee Brewers in the 1989 MLB draft. However, he chose to attend college instead, enrolling at Long Beach State University, where he majored in Business; while at college, he played baseball for the Long Beach State 49ers. In 1992 he was drafted by the Oakland Athletics in the second round of the MLB draft, playing for the single A Northwest League’s Southern Oregon A’s. However, he spent the majority of his summer playing for the US Olympic team that competed in Barcelona. Upon returning from the Olympics, he played for the Athletics’ single A farm team The Modesto’s A and also for the Southern League’s double A Huntsville Stars.
Giambi’s major league debut with the Athletics came in 1995. After achieving extraordinary results in on-base percentage and walks, and hitting .333 with 43 homers in 2000, he won the American League Most Valuable Player Award; his popularity was boosted. The following year saw similar statistics in Giambi’s play. He finished second in MVP voting, winning the Silver Slugger Award. Giambi’s tenure with the Athletics enabled him to acquire a considerable net worth.
Later that year, he signed a seven-year $120-million contract with the New York Yankees, significantly adding to his wealth. Although he had some success with the Yankees, it was foreshadowed by his involvement in the game’s preeminent performance-enhancing drug scandal in 2003. Reportedly, the player took anabolic steroids from his trainer Greg Anderson, obtained through BALCO, a laboratory that distributed performance-enhancing drugs to elite athletes. When the information reached the media, all eyes were on Giambi, who eventually confessed to the whole situation of taking the illegal drugs, apologizing publicly and urging others in the sport to do so. Surgery for a benign tumor in 2004 also hampered his form somewhat.
In 2009 Giambi signed with the Oakland Athletics again. However, his second stint with the team didn’t follow the success he had achieved before, and he was released by the Athletics later that year.
Not long afterwards, he signed with the Colorado Rockies and went on to play for the team’s AAA affiliate, the Colorado Springs Sky Sox. After returning to the Rockies in 2010, he hit three home runs in one game in 2011, for the first time in his career, being the second oldest player to achieve that.
In 2012 Giambi became a free agent. The following year he signed a minor league deal with the Cleveland Indians, re-signing to a one-year minor league deal later that year, improving his net worth once again. He retired from professional baseball in 2015.
When speaking about his private life, Giambi was married to Dana Mandela(1998-2000), and has been married to Kristian Rice since 2002; the couple has one child, and the family resides in Henderson, Nevada. The player is also involved in philanthropy, being a spokesman for CAP Cure, focused on raising money for and awareness of the fight against prostate cancer.
